葡萄糖合物疫苗:针对性免疫的平台和辅助剂
Valerie Lensch1, Jeremiah A Johnson1,2,3, Laura L Kiessling1,2,3
1Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, United States.
Glycobiology
|November 27, 2024
概括
葡萄糖合物疫苗可以改善对碳水化合物抗原的免疫反应. 新的联合疫苗平台优化了甘氨酸的显示,并结合了辅助剂,以更广泛地覆盖疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 碳水化合物化学 碳水化合物化学
背景情况:
- 细胞表面的甘氨酸涂层 - - 葡萄糖对于免疫识别和病原体检测至关重要.
- 碳水化合物抗原是疫苗的关键目标,但单独的免疫原通常很差.
- 葡萄糖合物疫苗,将碳水化合物与载体蛋白联系起来,增强抗体的产生.
研究的目的:
- 审查联合疫苗平台的进展,以改善基于碳水化合物的疫苗.
- 解决目前针对细胞内病原体和癌症的疫苗的局限性.
- 突出优化甘氨酸和T细胞表皮图表显示的策略,并结合碳水化合物辅助剂.
主要方法:
- 综述联合疫苗设计和实施的最新进展.
- 对增强碳水化合物抗原免疫性策略的分析.
- 探索针对定制免疫反应的新型辅助方法.
主要成果:
- 新的联合疫苗平台增强了甘氨酸和T细胞表位的显示.
- 纳入定义的碳水化合物辅助剂指导量身定制的免疫反应.
- 优化的平台有望克服当前基于碳水化合物的疫苗的局限性.
结论:
- 结合疫苗技术的进步为向碳水化合物抗原提供了改进的策略.
- 这些进展预计将扩大针对各种疾病的疫苗适用性,包括癌症和细胞内病原体.
- 优化甘氨酸和辅助剂的结合是开发更有效的基于碳水化合物的疫苗的关键.
更多相关视频
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10.4K
08:14Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
8.4K
相关概念视频
Conjugated Proteins
18.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.2K
Vaccinations
44.1K
Overview
44.1K
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
Antigens Involved in Adaptive Immunity
460
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
460
Humoral Immune Responses
71.6K
Overview
71.6K
Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K
